111 related articles for article (PubMed ID: 8435430)
1. Eisenin (L-pyroGlu-L-Gln-L-Ala), a new biological response modifier.
Kojima T; Koike A; Yamamoto S; Kanemitsu T; Miwa M; Kamei H; Kondo T; Iwata T
J Immunother Emphasis Tumor Immunol; 1993 Jan; 13(1):36-42. PubMed ID: 8435430
[TBL] [Abstract][Full Text] [Related]
2. Natural cytotoxicity of human blood monocytes and natural killer cells and their cytotoxic factors: discriminating effects of actinomycin D.
Uchida A; Klein E
Int J Cancer; 1985 May; 35(5):691-9. PubMed ID: 3997288
[TBL] [Abstract][Full Text] [Related]
3. Lysis of fresh solid tumor targets in the presence of Con A is mediated primarily by Leu 7+ peripheral blood T lymphocytes: blocking by the anti-CD3 monoclonal antibody and comparison with recombinant interleukin 2-induced lysis by natural killer cells.
Itoh K; Platsoucas CD; Tilden AB; Pollock RE; Balch CM
Cell Immunol; 1987 Sep; 108(2):283-96. PubMed ID: 3113741
[TBL] [Abstract][Full Text] [Related]
4. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
Uchida A; Vánky F; Klein E
J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
[TBL] [Abstract][Full Text] [Related]
5. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
6. Modulation of human natural killer cell function by L-leucine methyl ester: monocyte-dependent depletion from human peripheral blood mononuclear cells.
Thiele DL; Lipsky PE
J Immunol; 1985 Feb; 134(2):786-93. PubMed ID: 3965574
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of natural killer cell activity by ImuVert: a biological response modifier derived from Serratia marcescens.
Warren RP; McCall CA; Urban RW
Mol Biother; 1989; 1(3):145-51. PubMed ID: 2690869
[TBL] [Abstract][Full Text] [Related]
8. Monocyte- and natural killer cell-mediated spontaneous cytotoxicity against human noncultured solid tumor cells.
Itoh K; Platsoucas CD; Balch CM
Cell Immunol; 1987 Sep; 108(2):495-500. PubMed ID: 3113744
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin G enhances human natural killer cytotoxicity.
Yamazaki T; Aoki Y
Immunology; 1998 Jan; 93(1):115-21. PubMed ID: 9536127
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of natural killer activity in peripheral blood lymphocytes of healthy donors and melanoma patients in vitro: synergism between interleukin (IL)-12 and IL-15 or IL-12 and IL-2.
Seidel MG; Freissmuth M; Pehamberger H; Micksche M
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):382-9. PubMed ID: 9774227
[TBL] [Abstract][Full Text] [Related]
11. Natural anti-chondrocyte cytotoxicity of normal human peripheral blood mononuclear cells.
Malejczyk J
Clin Immunol Immunopathol; 1989 Jan; 50(1 Pt 1):42-52. PubMed ID: 2783400
[TBL] [Abstract][Full Text] [Related]
12. [Augmentation of natural killer (NK) cell activity in human blood lymphocytes by a new synthetic acyltripeptide (FK-565) and its derivatives].
Shimizu E; Tandon P; Utsugi T; Sone S
Gan To Kagaku Ryoho; 1986 Jul; 13(7):2353-7. PubMed ID: 3460529
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin-inducible monocyte cytotoxicity for K562 cells and decay of natural killer lymphocyte cytotoxicity.
McCormick JA; Markey GM; Morris TC
Clin Exp Immunol; 1991 Jan; 83(1):154-6. PubMed ID: 1988223
[TBL] [Abstract][Full Text] [Related]
14. Cytolysis of mammary tumor targets by resting, interleukin-2 stimulated and in vitro cultured peripheral blood lymphocytes from breast cancer patients.
Brenner BG; McCrea EL; Margolese RG
Anticancer Res; 1988; 8(4):653-8. PubMed ID: 3263077
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of natural killer cell activity in human immunodeficiency virus-infected subjects by in vitro treatment with biologic response modifier OK-432.
Huang XL; Fan Z; Murayama T; Rinaldo C
Clin Diagn Lab Immunol; 1995 Jan; 2(1):91-7. PubMed ID: 7719919
[TBL] [Abstract][Full Text] [Related]
16. Biological response modifier enhances the activity of natural killer cell against human cytomegalovirus-infected cells.
Murayama T; Natsuume-Sakai S; Xu B; Furukawa T; Rinaldo CR
J Med Virol; 1989 Oct; 29(2):102-8. PubMed ID: 2557379
[TBL] [Abstract][Full Text] [Related]
17. Sensitivity of ovarian tumor cells to effector cells generated by various biological response modifiers.
Nio Y; Zighelboim J; Berek JS; Bonavida B
Nat Immun Cell Growth Regul; 1990; 9(4):283-96. PubMed ID: 2215516
[TBL] [Abstract][Full Text] [Related]
18. Enrichment in tumor-reactive CD8+ T-lymphocytes by positive selection from the blood and lymph nodes of patients with head and neck cancer.
Letessier EM; Heo DS; Okarma T; Johnson JT; Herberman RB; Whiteside TL
Cancer Res; 1991 Aug; 51(15):3891-9. PubMed ID: 1677310
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of natural cytotoxicity by leucine enkephalin in cultured peripheral blood mononuclear cells from patients infected with human immunodeficiency virus.
Oleson D; Grierson H; Goldsmith J; Purtilo DT; Johnson D
Clin Immunol Immunopathol; 1989 Jun; 51(3):386-95. PubMed ID: 2721034
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro cytotoxicity of a methotrexate-anti-MM46 monoclonal antibody conjugate via an oligopeptide spacer.
Umemoto N; Kato Y; Endo N; Takeda Y; Hara T
Int J Cancer; 1989 Apr; 43(4):677-84. PubMed ID: 2784785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
